PT2310385T - Composição farmacêutica sólida - Google Patents

Composição farmacêutica sólida

Info

Publication number: PT2310385T
Authority: PT; Portugal
Prior art keywords: pharmaceutical composition; solid pharmaceutical; solid; composition; pharmaceutical
Prior art date: 2008-07-31

Application number

PT97880173T

Other languages

English (en)

Inventor

Tanoue Yutaka

Nomura Junya

Original Assignee

Takeda Pharmaceuticals Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-31

Filing date

2009-07-29

Publication date

2017-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41610805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2310385(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-07-29 Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co

2017-09-11 Publication of PT2310385T publication Critical patent/PT2310385T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT97880173T 2008-07-31 2009-07-29 Composição farmacêutica sólida PT2310385T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8520108P	2008-07-31	2008-07-31
US8562708P	2008-08-01	2008-08-01

Publications (1)

Publication Number	Publication Date
PT2310385T true PT2310385T (pt)	2017-09-11

Family

ID=41610805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97880173T PT2310385T (pt)	2008-07-31	2009-07-29	Composição farmacêutica sólida

Country Status (26)

Country	Link
US (1)	US9169238B2 (pt)
EP (1)	EP2310385B1 (pt)
JP (1)	JP5635491B2 (pt)
KR (1)	KR20110038145A (pt)
CN (1)	CN102164918B (pt)
AR (1)	AR072883A1 (pt)
AU (1)	AU2009277455A1 (pt)
BR (1)	BRPI0916847A2 (pt)
CA (1)	CA2732018C (pt)
CL (1)	CL2011000187A1 (pt)
CO (1)	CO6341633A2 (pt)
CR (1)	CR20110111A (pt)
DO (1)	DOP2011000032A (pt)
EA (1)	EA201170273A1 (pt)
EC (1)	ECSP11010856A (pt)
GE (1)	GEP20146062B (pt)
IL (1)	IL210819A0 (pt)
MA (1)	MA32553B1 (pt)
MX (1)	MX2011001150A (pt)
NZ (1)	NZ590948A (pt)
PE (1)	PE20110551A1 (pt)
PT (1)	PT2310385T (pt)
TW (1)	TW201008915A (pt)
UY (1)	UY32017A (pt)
WO (1)	WO2010013835A2 (pt)
ZA (1)	ZA201100871B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY32126A (es)	2008-09-25	2010-04-30	Takeda Pharmaceutical	Composición farmacéutica sólida
US9387249B2 (en)	2008-12-23	2016-07-12	Takeda Pharmaceutical Company Limited	Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
CN102351853B (zh) *	2011-08-29	2014-03-12	石药集团欧意药业有限公司	一种阿齐沙坦酯化合物、制备方法及其药物组合物
CA2882727A1 (en) *	2012-08-22	2014-02-27	Xenoport, Inc.	Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
JP6935301B2 (ja) *	2016-11-18	2021-09-15	花王株式会社	モノハロゲノアミン製造用被覆粒子群
IN202021028444A (pt) *	2020-07-03	2022-01-28

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4444769A (en) *	1982-07-27	1984-04-24	Mylan Pharmaceuticals, Inc.	Antihypertensive diuretic combination composition and associated method
IL102183A (en)	1991-06-27	1999-11-30	Takeda Chemical Industries Ltd	The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
CA2125251C (en) *	1993-06-07	2005-04-26	Yoshiyuki Inada	A pharmaceutical composition for angiotensin ii-mediated diseases
US5721263A (en)	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
JP3057471B2 (ja) *	1993-06-07	2000-06-26	武田薬品工業株式会社	アンジオテンシンｉｉ介在性諸疾患の予防または治療剤
EP1258254A4 (en)	2000-02-21	2004-02-04	Takeda Chemical Industries Ltd	COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
JP2001294524A (ja)	2000-04-12	2001-10-23	Taisho Pharmaceut Co Ltd	アセトアミノフェン配合内服固形製剤
FR2812876B1 (fr)	2000-08-08	2002-09-27	Galderma Res & Dev	Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
US20040147605A1 (en) *	2001-05-25	2004-07-29	Yoichi Onuki	Drug preparations
AU2002349673A1 (en)	2001-12-03	2003-06-17	Takeda Chemical Industries, Ltd.	Insulin resistance improving agents
DE10244681A1 (de)	2002-09-24	2004-04-08	Boehringer Ingelheim International Gmbh	Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
EP1648515B1 (en)	2003-07-16	2012-11-21	Boehringer Ingelheim International GmbH	Chlorthalidone combinations
US7157584B2 (en) *	2004-02-25	2007-01-02	Takeda Pharmaceutical Company Limited	Benzimidazole derivative and use thereof
US7625940B2 (en)	2005-07-01	2009-12-01	Accu-Break Technologies, Inc.	Method of treating hypertension with a very low dose of chlorthalidone
JPWO2006028007A1 (ja)	2004-09-06	2008-05-08	興和株式会社	糸球体疾患治療剤
US20070049636A1 (en)	2005-08-26	2007-03-01	Joerg Rosenberg	Pharmaceutical compositions
CA2589493A1 (en) *	2004-12-17	2006-06-22	Boehringer Ingelheim International Gmbh	Combination therapy comprising telmisartan and hydrochlorothiazide
US20060159747A1 (en)	2004-12-17	2006-07-20	Boehringer Ingelheim International Gmbh	Telmisartan and hydrochlorothiazide combination therapy
NZ562887A (en)	2005-03-30	2010-10-29	Takeda Pharmaceutical	Benzimidazole derivative and use as angiotensin II antagonist
EP1885694A2 (en)	2005-05-13	2008-02-13	Microbia, Inc.	4-biarylyl-1-phenylazetidin-2-ones
SI1897558T1 (sl) *	2005-06-09	2014-03-31	Norgine Bv	Trden pripravek 2-heksadeciloksi-6-metil-4h-3,1-benzoksazin-e-on
MX2009001429A (es)	2006-08-10	2009-02-17	Takeda Pharmaceutical	Composicion farmaceutica.
WO2008045006A1 (en)	2006-10-11	2008-04-17	Fako Ilaclari A. S.	Formulations of candesartan
WO2008068217A2 (en)	2006-12-04	2008-06-12	Boehringer Ingelheim International Gmbh	Pharmaceutical composition comprising a coated hmg-coa reductase inhibitor and an inhibitor of the renin-angiotensin system
CL2008000868A1 (es)	2007-03-28	2008-10-10	Takeda Pharmaceutical	Composicion farmaceutica solida que comprende un compuesto derivado de benzimidazol y un agente de control de ph; metodo de estabilizacion y de mejoramiento de la disolucion; uso de un agente de control de ph.
RU2010104960A (ru)	2007-08-01	2011-09-10	Тева Фармасьютикал Индастриес Лтд. (Il)	Фармацевтическая композиция кандесартана
EP2203158A4 (en)	2007-10-30	2012-12-26	Reddys Lab Ltd Dr	PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE
US9387249B2 (en)	2008-12-23	2016-07-12	Takeda Pharmaceutical Company Limited	Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

2009
- 2009-07-29 PT PT97880173T patent/PT2310385T/pt unknown
- 2009-07-29 PE PE2011000100A patent/PE20110551A1/es not_active Application Discontinuation
- 2009-07-29 EP EP09788017.3A patent/EP2310385B1/en active Active
- 2009-07-29 TW TW098125491A patent/TW201008915A/zh unknown
- 2009-07-29 KR KR1020117003910A patent/KR20110038145A/ko not_active Application Discontinuation
- 2009-07-29 EA EA201170273A patent/EA201170273A1/ru unknown
- 2009-07-29 AU AU2009277455A patent/AU2009277455A1/en not_active Abandoned
- 2009-07-29 NZ NZ590948A patent/NZ590948A/en not_active IP Right Cessation
- 2009-07-29 UY UY0001032017A patent/UY32017A/es not_active Application Discontinuation
- 2009-07-29 US US12/737,612 patent/US9169238B2/en active Active
- 2009-07-29 BR BRPI0916847A patent/BRPI0916847A2/pt not_active IP Right Cessation
- 2009-07-29 MX MX2011001150A patent/MX2011001150A/es unknown
- 2009-07-29 CN CN200980138066.4A patent/CN102164918B/zh active Active
- 2009-07-29 WO PCT/JP2009/063833 patent/WO2010013835A2/en active Application Filing
- 2009-07-29 AR ARP090102885A patent/AR072883A1/es not_active Application Discontinuation
- 2009-07-29 JP JP2011503295A patent/JP5635491B2/ja active Active
- 2009-07-29 CA CA2732018A patent/CA2732018C/en active Active
- 2009-07-29 GE GEAP200912119A patent/GEP20146062B/en unknown
2011
- 2011-01-23 IL IL210819A patent/IL210819A0/en unknown
- 2011-01-28 CL CL2011000187A patent/CL2011000187A1/es unknown
- 2011-01-28 DO DO2011000032A patent/DOP2011000032A/es unknown
- 2011-02-02 ZA ZA2011/00871A patent/ZA201100871B/en unknown
- 2011-02-11 MA MA33604A patent/MA32553B1/fr unknown
- 2011-02-28 EC EC2011010856A patent/ECSP11010856A/es unknown
- 2011-02-28 CR CR20110111A patent/CR20110111A/es not_active Application Discontinuation
- 2011-02-28 CO CO11023785A patent/CO6341633A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN102164918B (zh)	2014-05-07
AU2009277455A1 (en)	2010-02-04
JP2011529444A (ja)	2011-12-08
AR072883A1 (es)	2010-09-29
CR20110111A (es)	2011-04-28
CA2732018A1 (en)	2010-02-04
CL2011000187A1 (es)	2011-06-24
KR20110038145A (ko)	2011-04-13
EA201170273A1 (ru)	2011-08-30
DOP2011000032A (es)	2011-02-28
ECSP11010856A (es)	2011-03-31
WO2010013835A2 (en)	2010-02-04
EP2310385B1 (en)	2017-06-07
MX2011001150A (es)	2011-03-29
JP5635491B2 (ja)	2014-12-03
GEP20146062B (en)	2014-03-25
PE20110551A1 (es)	2011-09-02
WO2010013835A3 (en)	2010-06-10
US9169238B2 (en)	2015-10-27
UY32017A (es)	2010-02-26
EP2310385A2 (en)	2011-04-20
TW201008915A (en)	2010-03-01
US20110123615A1 (en)	2011-05-26
CO6341633A2 (es)	2011-11-21
IL210819A0 (en)	2011-04-28
NZ590948A (en)	2012-06-29
CA2732018C (en)	2017-07-04
ZA201100871B (en)	2012-05-30
BRPI0916847A2 (pt)	2016-02-10
CN102164918A (zh)	2011-08-24
MA32553B1 (fr)	2011-08-01

Publication	Publication Date	Title
HUS1800007I1 (hu)	2018-03-28	Gyógyászati készítmény
IL228817A0 (en)	2013-12-31	Pharmaceutical compounds
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en)	2008-09-17	Pharmaceutical compositions
EP2133095A4 (en)	2012-09-26	PHARMACEUTICAL COMPOSITION
EP2133094A4 (en)	2010-10-13	PHARMACEUTICAL COMPOSITION
EP2191826A4 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
PT2323623T (pt)	2016-11-04	Composições farmacêuticas
IL200125A0 (en)	2010-04-15	Pharmaceutical composition
EP2224805A4 (en)	2013-10-16	PHARMACEUTICAL COMPOSITION
ZA201102715B (en)	2012-07-25	Solid pharmaceutical composition
EP2224915A4 (en)	2014-01-22	PHARMACEUTICAL COMPOSITIONS
IL208387A0 (en)	2010-12-30	Pharmaceutical composition
HK1138774A1 (en)	2010-09-03	Pharmaceutical composition
EP2224808A4 (en)	2013-11-27	PHARMACEUTICAL COMPOSITION
ZA201100871B (en)	2012-05-30	Solid pharmaceutical composition
EP2156832A4 (en)	2010-11-24	PHARMACEUTICAL COMPOSITION
ZA201006224B (en)	2011-11-30	Pharmaceutical composition
EP2327406A4 (en)	2014-04-09	STABILIZED PHARMACEUTICAL COMPOSITION
GB2464200B (en)	2013-05-08	Pharmaceutical composition
IL206487A0 (en)	2010-12-30	Pharmaceutical compositions
EP2224806A4 (en)	2014-02-19	PHARMACEUTICAL COMPOSITION
GB0817969D0 (en)	2008-11-05	Pharmaceutical composition
HK1182939A1 (en)	2013-12-13	Stable pharmaceutical composition